行情

OGEN

OGEN

ORAGENICS
AMEX

实时行情|Nasdaq Last Sale

0.7248
+0.0138
+1.94%
盘后: 0.7400 +0.0152 +2.10% 19:53 06/17 EDT
开盘
0.7108
昨收
0.7110
最高
0.7573
最低
0.7108
成交量
90.48万
成交额
--
52周最高
2.090
52周最低
0.3770
市值
8,381.46万
市盈率(TTM)
-1.6970
分时
5日
1月
3月
1年
5年
简介-Oragenics向股东发出信
reuters.com · 05/18 11:43
10-Q:ORAGENICS INC
(EDGAR Online via COMTEX) -- ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following information should...
Edgar Online - (EDG = 10Q, 10K) · 05/03 20:14
Brief-Oragenics宣布管理层和董事会变动
reuters.com · 05/03 12:19
Oragenics宣布管理层和董事会变动
BusinessWire - BZX · 05/03 11:30
OGEN:COVID-19疫苗候选人在小鼠中表现出保护性免疫力…
By David Bautz, PhD NYSE:OGEN READ THE FULL OGEN RESEARCH REPORT
Benzinga · 04/14 14:31
8-K:ORAGENICS INC
Edgar Online - (EDK = 8-Ks/S1/S-4) · 04/01 21:51
Oragenics的COVID-19相关交易推动股价上涨
Oragenics Inc (NYSE: OGEN) stock is soaring higher after 
Benzinga · 03/09 17:10
周五前值得关注的最佳生物科技竹enny股票
Mar 09, 2021 (Penny Stocks via COMTEX) -- Biotech Penny Stocks To Watch Right Now While penny stocks are well-known for volatility, so too are certain...
Penny Stocks · 03/09 14:28
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解OGEN最新的财务预测,通过OGEN每股收益,每股净资产,每股现金流等数据分析ORAGENICS近期的经营情况,然后做出明智的投资选择。
分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测OGEN价格均价为2.000,最高价位2.000,最低价为2.000。
EPS
机构持股
总机构数: 18
机构持股: 632.58万
持股比例: 5.47%
总股本: 1.16亿
类型机构数股数
增持
4
85.73万
建仓
5
12.88万
减持
2
270.82万
平仓
2
298.15万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
+0.60%
制药与医学研究
+0.27%
高管信息
Chairman/Executive Director
Frederick Telling
Chief Executive Officer/Chief Financial Officer/Treasurer/Secretary
Michael Sullivan
Director
Kim Murphy
Independent Director
Alan Dunton
Independent Director
Robert Koski
Independent Director
Charles Pope
暂无数据
OGEN 简况
Oragenics, Inc. is a healthcare company. The Company is focused on developing treatments for oral mucositis and novel antibiotics against infectious disease. The Company is focused on developing of the TerraCoV2 immunization product candidate. The Company’s product candidate includes, OG716, as an antibiotic, as well as other homolog antibiotic product candidates and AG013 for the treatment of oral mucositis in patients undergoing treatment for cancer. The Company have developed other product such as weight loss candidate, LPT3-04 and SMaRT Replacement Therapy.

微牛提供Oragenics Inc(AMEX-OGEN)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的OGEN股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易OGEN股票基本功能。